Anti Viral

  • Ledibiox 90-400 3D Layer

    Ledibiox®

    Ledibiox is indicated for the treatment of chronic hepatitis C (CHC) genotype 1 infection in adults.

  • Daklibiox 30-60 3D

    Daklibiox®

    Daklibiox is indicated for use with sofosbuvir for the treatment of patients with chronic hepatitis C virus (HCV) genotype 3 infection.

  • Sobiovir 400

    Sobiovir®

    Sobiovir indicated for the treatment of chronic hepatitis C (CHC) infection as a component of a combination antiviral treatment regimen. 

  • Biovirapine

    Biovirapine®

    Nevirapine: Biovirapine is indicated for use in combination with other antiretroviral agents for the treatment of HIV-1-infection.

  • Valbiovir

    Valbiovir®

    Valacyclovir: Herpes genitalis Herpes zoster

  • Cytobiovir

    Cytobiovir®

    Valgancyclovir: For treatment of CMV-infections

  • Tenobiovir

    Tenobiovir®

    Tenofovir disoproxil fumarate:Tenobiovir is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection or chronic hepatitis B virus infection in patients who are also infected with HIV.

  • Efabiovir

    Efabiovir®

    Efabiovir in combination with other antiretroviral agents is indicated for the treatment of HIV-1 infection.

  • Co-biovir

    Co-Biovir®

    Zidovudine / Lamivudine: This Combination is indicated in the treatment of HIV infection.

  • Biofovir

    Biofovir®

    Adefovir: Biofovir is indicated for the treatment of chronic hepatitis B in adults with evidence of active viral replication and either evidence of persistent elevations in serum aminotransferases (ALT or AST) or histologically active disease.

Copyright © 2017 Bakhtar Bioshimi Co, All rights reserved.